Остеопороз и остеопатии, 2013 This review of the literature has been dedicated to experimental and clinical studies of mechanism of action and efficacy of 1—34 amino acid fragment of parathyroid hormone — teriparatide as well as others contries experience of its prescribtion ...
Zh E BELAYa, L Ya ROZhINSKAYa
doaj +1 more source
Suitability of teriparatide and level of acceptance of pharmacotherapeutic recommendations in a healthcare management areaSuitability of teriparatide and level of acceptance of pharmacotherapeutic recommendations in a healthcare management area DOI: 10.7399/fh.2016.40.4.9953 [PDF]
Farmacia Hospitalaria, 2016 Objective: To analyse the suitability of teriparatide prescriptions for osteoporosis treatment in a health management area, as well as the level of acceptance of pharmacotherapeutic recommendations made to physicians. Design: A prospective interventional
Maria Rosa Cantudo-Cuenca +5 more
doaj +1 more source
Therapy of Osteoporosis in Men with Teriparatide
Journal of Osteoporosis, 2011 Osteoanabolic therapy is an attractive therapeutic option for men with osteoporosis because it directly stimulates bone formation, an action not shared by any antiresorptive drug.
Natalie E. Cusano +3 more
doaj +1 more source
JBMR Plus, 2019 Teriparatide, currently only available in brand form in the United States, is a costly drug approved for the treatment of postmenopausal osteoporotic women who are at high risk of fracture.
Takahiro Mori +2 more
doaj +1 more source
Acta Orthopaedica, 2018 Background and purpose — Teriparatide accelerates fracture healing in animals and probably in man. Abaloparatide is a new drug with similar although not identical effects on the teriparatide receptor.
Magnus Bernhardsson, Per Aspenberg
doaj +1 more source
More than 6 Months of Teriparatide Treatment Was More Effective for Bone Union than Shorter Treatment Following Lumbar Posterolateral Fusion Surgery [PDF]
Asian Spine Journal, 2015 Study DesignRetrospective case series.PurposeTo examine the most effective duration of teriparatide use for spinal fusion in women with postmenopausal osteoporosis.Overview of LiteratureWe reported that daily subcutaneous injection of teriparatide ...
Seiji Ohtori +19 more
doaj +1 more source
Teriparatide Induced Delayed Persistent Hypercalcemia
Case Reports in Endocrinology, 2014 Teriparatide, a recombinant PTH, is an anabolic treatment for osteoporosis that increases bone density. Transient hypercalcemia is a reported side effect of teriparatide that is seen few hours following administration of teriparatide and resolves usually
Nirosshan Thiruchelvam +3 more
doaj +1 more source
Journal of Orthopaedic Surgery and Research, 2023 Background Continuous use of glucocorticoids (GCs) has become the primary cause of secondary osteoporosis. Bisphosphonate drugs were given priority over denosumab and teriparatide in the 2017 American College of Rheumatology (ACR) guidelines but have a ...
Chuanjian Yuan +3 more
doaj +1 more source
Effectiveness of Teriparatide on Fracture Healing: A Systematic Review and Meta-Analysis.
PLoS ONE, 2016 PurposeNowadays, the efficacy of teriparatide in treating osteoporosis was widely accepted, but the discussion about using teriparatide to enhance fracture healing hasn't come to an agreement.
Zhongju Shi +7 more
doaj +1 more source
Does Discontinuing Teriparatide Treatment and Replacing It with Bisphosphonate Maintain the Volume of the Bone Fusion Mass after Lumbar Posterolateral Fusion in Women with Postmenopausal Osteoporosis? [PDF]
Asian Spine Journal, 2017 Study DesignRetrospective case series.PurposeThe purpose of this study was to determine whether discontinuing teriparatide treatment and replacing it with bisphosphonate treatment maintains the volume of the fusion mass after posterolateral fusion (PLF ...
Seiji Ohtori +16 more
doaj +1 more source